Cargando…
TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy
Myelosuppression is a life-threatening complication of antineoplastic therapy, but treatment is restricted to a few cytokines with unilineage hematopoietic activity. Although hematopoietic stem cells (HSCs) are predominantly quiescent during homeostasis, they are rapidly recruited into cell cycle by...
Autores principales: | Brenet, Fabienne, Kermani, Pouneh, Spektor, Roman, Rafii, Shahin, Scandura, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600905/ https://www.ncbi.nlm.nih.gov/pubmed/23440043 http://dx.doi.org/10.1084/jem.20121610 |
Ejemplares similares
-
Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression
por: Brenet, Fabienne, et al.
Publicado: (2015) -
Endothelial jagged-2 sustains hematopoietic stem and progenitor reconstitution after myelosuppression
por: Guo, Peipei, et al.
Publicado: (2017) -
Reversal of emphysema by restoration of pulmonary endothelial cells
por: Hisata, Shu, et al.
Publicado: (2021) -
Infusion of allogeneic umbilical cord blood hematopoietic stem cells in patients with chemotherapy-related myelosuppression
por: YAO, YI, et al.
Publicado: (2014) -
Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
por: Zhang, Shiyu, et al.
Publicado: (2022)